Neurovascular Devices - Global Market Outlook (2017-2026)

March 2019 | 133 pages | ID: NDD96EFB862EN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Neurovascular Devices Market is accounted for $1.90 billion in 2017 and is expected to reach $4.35 billion by 2026 growing at a CAGR of 9.6% from 2017 to 2026. Some of the key factors influencing the market growth are favorable medical reimbursements, rising target patient population and enhanced effectiveness and better patient outcomes. Moreover, rising number of researches in neurovascular therapies and rising demand for minimally invasive procedures will provide ample opportunities for the growth of the market. However, commercialization across developing economies and lack of skilled neurosurgeons are hampering the market growth.

Neurological devices/Interventional neurology is the non-surgical specialty that uses minimally invasive, image guided techniques for the treatment of most complex and dangerous diseases of neck, brain, and spine. Neurovascular devices are extensively used for the treatment of neurovascular diseases like brain aneurysm, arteriovenous malformations (AVMs), and others. A variety of material such as nitinol, cobalt, platinum can be used in neurovascular devices to achieve the specialized characteristics for aneurysm repair and ischemic stroke prevention.

By Therapeutic Application, the Ischemic strokes segment is anticipated to grow during the forecast period due to growing patient pool suffering from ischemic stroke. Ischemic stroke occurs when a blood vessel carrying blood to the brain is blocked by a blood clot. By geography, North America has the highest market growth during the forecast period due to high pervasiveness of brain aneurysms. In U.S, High prevalence of ischemic stroke and stenosis will influence the growth.

Some of the key players include Penumbra, Inc., Johnson & Johnson, Microport Scientific Corporation, Abbott Laboratories, Stryker Corporation, Medtronic PLC , Terumo Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, Inc., Boston Scientific Corporation, LivaNova PLC, Kaneka Medix Corp, Integra Lifesciences, Asahi Intecc CO., LTD, and Integer Holdings Corporation.

Disease Pathologies Covered:

• Arteriovenous Malformation and Fistulas
• Ischemic Strokes
• Cerebral Aneurysms
• Stenosis

Processes Covered:

• Stenting technique
• Neurothrombectomy procedure
• Coiling procedure technique
• Cerebral angiography technique
• Flow disruption technique

Products Covered:

• Cerebral Balloon Angioplasty and Stenting Systems
• Support Devices
• Aneurysm Coiling & Embolization Devices
• Neurothrombectomy Devices
• Revascularization Devices
• Accessory Devices
• Other Products

Therapeutic Applications covered :

• Ischemic strokes
• Cerebral Artery Stenosis
• Brain Aneurysm
• Other
• Hemorrhagic Stroke
• Therapeutic Application

End User:

• Ambulatory Surgical Units
• Hospitals
• Clinics

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• UK
• Italy
• France
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• South Korea
• Rest of Asia Pacific
• South America
• Argentina
• Brazil
• Chile
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• UAE
• Qatar
• South Africa
• Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country level segments
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
• Comprehensive profiling of additional market players (up to 3)
• SWOT Analysis of key players (up to 3)
• Regional Segmentation
• Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
• Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End user Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY

5.1 Introduction
5.2 Arteriovenous Malformation and Fistulas
5.3 Ischemic Strokes
5.4 Cerebral Aneurysms
5.5 Stenosis
5.6 Other Disease Pathologies

6 GLOBAL NEUROVASCULAR DEVICES MARKET, BY PROCESS

6.1 Introduction
6.2 Stenting Technique
6.3 Neurothrombectomy Procedure
6.4 Coiling Procedure Technique
6.5 Cerebral Angiography Technique
6.6 Flow Disruption Technique

7 GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT

7.1 Introduction
7.2 Cerebral Balloon Angioplasty and Stenting Systems
  7.2.1 Embolic Protection Systems
    7.2.1.1 Distal Filter Devices
    7.2.1.2 Balloon Occlusion Devices
  7.2.2 Carotid Artery Stents
7.3 Support Devices
  7.3.1 Micro Guidewires
  7.3.2 Micro Catheters
7.4 Aneurysm Coiling & Embolization Devices
  7.4.1 Liquid Embolic Agents
  7.4.2 Clippings
  7.4.3 Embolic Coils
    7.4.3.1 Coated Detachable Coils
    7.4.3.2 Bare Detachable Coils
  7.4.4 Coil Assist Stent
  7.4.5 Coil Assist Balloon
7.5 Neurothrombectomy Devices
  7.5.1 Suction and Aspiration Devices
  7.5.2 Clot Retrieval Devices
  7.5.3 Snares
7.6 Revascularization Devices
  7.6.1 Flow Diversion Stents
  7.6.2 Carotid Artery Stents
7.7 Other Products
  7.7.1 Intracranial Stents
  7.7.2 Stent Retrievers

8 GLOBAL NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION

8.1 Introduction
8.2 Brain Aneurysm
8.3 Therapeutic Application
8.4 Cerebral Artery Stenosis
8.5 Ischemic Strokes
8.6 Hemorrhagic Stroke
8.7 Other Therapeutic Applications

9 GLOBAL NEUROVASCULAR DEVICES MARKET, BY END USER

9.1 Introduction
9.2 Ambulatory Surgical Units
9.3 Hospitals
9.4 Clinics

10 GLOBAL NEUROVASCULAR DEVICES MARKET, BY GEOGRAPHY

10.1 Introduction
10.2 North America
  10.2.1 US
  10.2.2 Canada
  10.2.3 Mexico
10.3 Europe
  10.3.1 Germany
  10.3.2 UK
  10.3.3 Italy
  10.3.4 France
  10.3.5 Spain
  10.3.6 Rest of Europe
10.4 Asia Pacific
  10.4.1 Japan
  10.4.2 China
  10.4.3 India
  10.4.4 Australia
  10.4.5 New Zealand
  10.4.6 South Korea
  10.4.7 Rest of Asia Pacific
10.5 South America
  10.5.1 Argentina
  10.5.2 Brazil
  10.5.3 Chile
  10.5.4 Rest of South America
10.6 Middle East & Africa
  10.6.1 Saudi Arabia
  10.6.2 UAE
  10.6.3 Qatar
  10.6.4 South Africa
  10.6.5 Rest of Middle East & Africa

11 KEY DEVELOPMENTS

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 COMPANY PROFILING

12.1 Penumbra, Inc.
12.2 Johnson & Johnson
12.3 Microport Scientific Corporation
12.4 Abbott Laboratories
12.5 Stryker Corporation
12.6 Medtronic PLC
12.7 Terumo Corporation
12.8 Merit Medical Systems, Inc.
12.9 W.L. Gore & Associates, Inc.
12.10 Boston Scientific Corporation
12.11 LivaNova PLC
12.12 Kaneka Medix Corp
12.13 Integra Lifesciences
12.14 Asahi Intecc CO., LTD
12.15 Integer Holdings Corporation

List Of Tables

LIST OF TABLES

Table 1 Global Neurovascular Devices Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Neurovascular Devices Market Outlook, By Disease Pathology (2016-2026) ($MN)
Table 3 Global Neurovascular Devices Market Outlook, By Arteriovenous Malformation and Fistulas (2016-2026) ($MN)
Table 4 Global Neurovascular Devices Market Outlook, By Ischemic Strokes (2016-2026) ($MN)
Table 5 Global Neurovascular Devices Market Outlook, By Cerebral Aneurysms (2016-2026) ($MN)
Table 6 Global Neurovascular Devices Market Outlook, By Stenosis (2016-2026) ($MN)
Table 7 Global Neurovascular Devices Market Outlook, By Other Disease Pathologies (2016-2026) ($MN)
Table 8 Global Neurovascular Devices Market Outlook, By Process (2016-2026) ($MN)
Table 9 Global Neurovascular Devices Market Outlook, By Stenting Technique (2016-2026) ($MN)
Table 10 Global Neurovascular Devices Market Outlook, By Neurothrombectomy Procedure (2016-2026) ($MN)
Table 11 Global Neurovascular Devices Market Outlook, By Coiling Procedure Technique (2016-2026) ($MN)
Table 12 Global Neurovascular Devices Market Outlook, By Cerebral Angiography Technique (2016-2026) ($MN)
Table 13 Global Neurovascular Devices Market Outlook, By Flow Disruption Technique (2016-2026) ($MN)
Table 14 Global Neurovascular Devices Market Outlook, By Product (2016-2026) ($MN)
Table 15 Global Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty and Stenting Systems (2016-2026) ($MN)
Table 16 Global Neurovascular Devices Market Outlook, By Embolic Protection Systems (2016-2026) ($MN)
Table 17 Global Neurovascular Devices Market Outlook, By Carotid Artery Stents (2016-2026) ($MN)
Table 18 Global Neurovascular Devices Market Outlook, By Support Devices (2016-2026) ($MN)
Table 19 Global Neurovascular Devices Market Outlook, By Micro Guidewires (2016-2026) ($MN)
Table 20 Global Neurovascular Devices Market Outlook, By Micro Catheters (2016-2026) ($MN)
Table 21 Global Neurovascular Devices Market Outlook, By Aneurysm Coiling & Embolization Devices (2016-2026) ($MN)
Table 22 Global Neurovascular Devices Market Outlook, By Liquid Embolic Agents (2016-2026) ($MN)
Table 23 Global Neurovascular Devices Market Outlook, By Clippings (2016-2026) ($MN)
Table 24 Global Neurovascular Devices Market Outlook, By Embolic Coils (2016-2026) ($MN)
Table 25 Global Neurovascular Devices Market Outlook, By Coil Assist Stent (2016-2026) ($MN)
Table 26 Global Neurovascular Devices Market Outlook, By Coil Assist Balloon (2016-2026) ($MN)
Table 27 Global Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2016-2026) ($MN)
Table 28 Global Neurovascular Devices Market Outlook, By Suction and Aspiration Devices (2016-2026) ($MN)
Table 29 Global Neurovascular Devices Market Outlook, By Clot Retrieval Devices (2016-2026) ($MN)
Table 30 Global Neurovascular Devices Market Outlook, By Snares (2016-2026) ($MN)
Table 31 Global Neurovascular Devices Market Outlook, By Revascularization Devices (2016-2026) ($MN)
Table 32 Global Neurovascular Devices Market Outlook, By Flow Diversion Stents (2016-2026) ($MN)
Table 33 Global Neurovascular Devices Market Outlook, By Carotid Artery Stents (2016-2026) ($MN)
Table 34 Global Neurovascular Devices Market Outlook, By Other Products (2016-2026) ($MN)
Table 35 Global Neurovascular Devices Market Outlook, By Intracranial Stents (2016-2026) ($MN)
Table 36 Global Neurovascular Devices Market Outlook, By Stent Retrievers (2016-2026) ($MN)
Table 37 Global Neurovascular Devices Market Outlook, By Therapeutic Application (2016-2026) ($MN)
Table 38 Global Neurovascular Devices Market Outlook, By Brain Aneurysm (2016-2026) ($MN)
Table 39 Global Neurovascular Devices Market Outlook, By Therapeutic Application (2016-2026) ($MN)
Table 40 Global Neurovascular Devices Market Outlook, By Cerebral Artery Stenosis (2016-2026) ($MN)
Table 41 Global Neurovascular Devices Market Outlook, By Ischemic Strokes (2016-2026) ($MN)
Table 42 Global Neurovascular Devices Market Outlook, By Hemorrhagic Stroke (2016-2026) ($MN)
Table 43 Global Neurovascular Devices Market Outlook, By Other Therapeutic Applications (2016-2026) ($MN)
Table 44 Global Neurovascular Devices Market Outlook, By End User (2016-2026) ($MN)
Table 45 Global Neurovascular Devices Market Outlook, By Ambulatory Surgical Units (2016-2026) ($MN)
Table 46 Global Neurovascular Devices Market Outlook, By Hospitals (2016-2026) ($MN)

Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the above manner.